1. Home
  2. WST vs SBAC Comparison

WST vs SBAC Comparison

Compare WST & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • SBAC
  • Stock Information
  • Founded
  • WST 1923
  • SBAC 1989
  • Country
  • WST United States
  • SBAC United States
  • Employees
  • WST N/A
  • SBAC N/A
  • Industry
  • WST Medical/Dental Instruments
  • SBAC Real Estate Investment Trusts
  • Sector
  • WST Health Care
  • SBAC Real Estate
  • Exchange
  • WST Nasdaq
  • SBAC Nasdaq
  • Market Cap
  • WST 20.1B
  • SBAC 20.2B
  • IPO Year
  • WST N/A
  • SBAC 1999
  • Fundamental
  • Price
  • WST $279.49
  • SBAC $193.63
  • Analyst Decision
  • WST Strong Buy
  • SBAC Buy
  • Analyst Count
  • WST 9
  • SBAC 14
  • Target Price
  • WST $354.50
  • SBAC $242.93
  • AVG Volume (30 Days)
  • WST 728.0K
  • SBAC 1.1M
  • Earning Date
  • WST 10-23-2025
  • SBAC 11-03-2025
  • Dividend Yield
  • WST 0.31%
  • SBAC 2.29%
  • EPS Growth
  • WST 0.17
  • SBAC 71.76
  • EPS
  • WST 6.75
  • SBAC 8.15
  • Revenue
  • WST $3,017,900,000.00
  • SBAC $2,724,524,000.00
  • Revenue This Year
  • WST $6.49
  • SBAC $6.84
  • Revenue Next Year
  • WST $6.23
  • SBAC $2.41
  • P/E Ratio
  • WST $41.44
  • SBAC $23.74
  • Revenue Growth
  • WST 4.92
  • SBAC 1.82
  • 52 Week Low
  • WST $187.43
  • SBAC $185.45
  • 52 Week High
  • WST $348.90
  • SBAC $245.16
  • Technical
  • Relative Strength Index (RSI)
  • WST 54.05
  • SBAC 46.07
  • Support Level
  • WST $272.99
  • SBAC $188.64
  • Resistance Level
  • WST $288.36
  • SBAC $194.19
  • Average True Range (ATR)
  • WST 9.46
  • SBAC 4.47
  • MACD
  • WST -0.68
  • SBAC 0.18
  • Stochastic Oscillator
  • WST 31.13
  • SBAC 49.17

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About SBAC SBA Communications Corporation

SBA Communications owns a portfolio of about 45,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by the top few mobile carriers. It owns more than 17,000 towers in the US, which account for about 75% of leasing revenue. Internationally, SBA's largest presence is in Brazil, where it owns roughly 10,000 towers. SBA operates as a real estate investment trust.

Share on Social Networks: